top of page
Lilly Acquires Scorpion Therapeutics’ Breast Cancer Treatment Program in $2.5B Deal
Pharmaceutical giant Eli Lilly has taken a significant step forward in breast cancer treatment by acquiring Scorpion Therapeutics’ PI3Kα...
The Female Body
Jan 242 min read
4 views
0 comments
Promising Breakthrough in Ovarian Cancer Treatment: Merck's Positive Phase 3 Trial Results
Merck has announced a significant step forward in ovarian cancer research with the successful results of its Phase 3 KEYLYNK-001 trial ,...
The Female Body
Dec 12, 20243 min read
0 views
0 comments
bottom of page